[1]
“THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION: T-AML predisposition”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023064, Oct. 2023, doi: 10.4084/MJHID.2023.064.